Press "Enter" to skip to content

New tentative approval for Xiamen Lp drug topiramate

0
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

[![topiramate structure](https://www.DrugPatentWatch.com/img/drug-structure/topiramate.png)](//www.DrugPatentWatch.com/p/preview/generic-api/topiramate?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog)
Topiramate is the generic ingredient in six branded drugs marketed by Upsher Smith Labs, Actavis Labs Fl, Ajanta Pharma Ltd, Alkem Labs Ltd, Dr Reddys, Glenmark Pharms Ltd, Par Pharm, Zydus, Zydus Pharms, Supernus Pharms, Janssen Pharms, Aurobindo Pharma Ltd, Barr, Fosun Pharma, Strides Pharma, Teva, Twi Pharms, Watson Labs, Zydus Pharms Usa Inc, Azurity, Accord Hlthcare, Actavis Totowa, Aiping Pharm Inc, Ascent Pharms Inc, Aurobindo Pharma, Chartwell, Cipla Ltd, Glenmark Generics, Hikma Pharms, Invagen Pharms, Mylan, Pliva Hrvatska Doo, Roxane, Sun Pharm, Sun Pharm Inds Ltd, Torrent Pharms, Unichem Labs Ltd, Viwit Pharm, and Wockhardt and, and is included in forty-five NDAs. There are eighteen patents protecting this compound.

TOPIRAMATE drug price trends.

Drug patent litigation for TOPIRAMATE.

This ingredient has twenty-one patent family members in eleven countries.

Fifty-one suppliers are listed for this compound. There are five tentative approvals for this compound.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions